No black box warning on record for Testosterone Cypionate

As of the latest FDA labeling reviewed, Testosterone Cypionate (TESTOSTERONE CYPIONATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Testosterone Cypionate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Hypercalcemia may occur in immobilized patients. If this occurs, the drug should be discontinued. Prolonged use of high doses of androgens (principally the 17-α alkyl-androgens) has been associated with development of hepatic adenomas, hepatocellular carcinoma, and peliosis hepatis —all potentially life-threatening complications. Geriatric patients treated with androgens may be at an incr

No black box warning on record for Testosterone Cypionate

Other warnings & precautions

WARNINGS Hypercalcemia may occur in immobilized patients. If this occurs, the drug should be discontinued. Prolonged use of high doses of androgens (principally the 17-α alkyl-androgens) has been associated with development of hepatic adenomas, hepatocellular carcinoma, and peliosis hepatis —all potentially life-threatening complications. Geriatric patients treated with androgens may be at an incr

Testosterone Cypionate Black Box Warning

No black box warning on record for Testosterone Cypionate

Other warnings & precautions

Testosterone Cypionate Black Box Warning

No black box warning on record for Testosterone Cypionate

Other warnings & precautions